VBC News Biorational Research Center Corporate Social Responsibility Osage Plant Quality in Manufacturing January 12, 2022Valent BioSciences Announces Osage Facility Environmental Initiatives September 23, 2021Valent BioSciences and Kansas State University Sign Collaborative Agreement for Soil Health Research Initiative with Dr. Charles W. Rice July 1, 2021Valent BioSciences Announces U.S. EPA Registration of AccedeTM Plant Growth Regulator for Effective Thinning of Stone Fruit and Apples June 23, 2021Valent BioSciences and Valent U.S.A. Collaborate with Halo on Open Innovation Initiative Seeking New Technologies and Solutions May 5, 2021Valent BioSciences Introduces MetaLarv® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats March 5, 2021Valent BioSciences Celebrates 50th Anniversary of DiPel® Biological Insecticide as the Industry’s Most Effective Lepidopteran Control Product December 3, 2020Valent BioSciences Announces New Educational Initiatives Supporting World Soil Day, Healthy Soils, and Sustainable Crop Production November 19, 2020Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory October 27, 2020SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies September 23, 2020Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth September 17, 2020Valent BioSciences Moves into New Global Biorational Headquarters July 25, 2018Valent BioSciences Unveils New Biorational Research Center July 11, 2016Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative March 31, 2016Valent BioSciences Corporation and Rizobacter Enter R&D Cooperation Agreement for Biorationals March 28, 2016Valent BioSciences Corporation Reaches Global Licensing Agreement with LidoChem, Inc. for New Biocontrol Technology to Protect Against Nematodes January 19, 2016Valent BioSciences Corporation Reaches Distribution Deal for Actinovate® Brands with The BioAg Alliance March 4, 2015Valent BioSciences Corporation Acquires Mycorrhizal Applications, Inc. June 27, 2014Valent BioSciences Corporation Unveils its State-of-the-Art Biorational Manufacturing Facility in Osage, Iowa February 4, 2014Valent BioSciences Corporation, Biomar Microbial Technologies Enter into Long-Term Strategic Alliance December 11, 2013Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following a System-Wide Audit October 22, 2013Richards Joins Valent BioSciences Corporation as Plant Manager for new Osage Manufacturing Facility August 19, 2013Ted Melnik Joins Valent BioSciences as Executive Vice President & Chief Operating Officer June 21, 2013Martin Joins Valent BioSciences Corporation as Manager, Global Field Research and Development June 19, 2013Storey Joins Valent BioSciences Corporation as Global Business Manager, Ag Microbials April 4, 2013Valent BioSciences’ $150M New Manufacturing Facility On Track for Completion in Iowa February 27, 2013Valent BioSciences to Sell Pace International Preharvest Products through Valent U.S.A. Corporation December 19, 2012Valent BioSciences Corporation Acquires Pace International November 1, 2012Mir Joins Valent BioSciences Corporation as Vice President, Global Marketing & Business Management March 16, 2012Groundbreaking Ceremony for Valent BioSciences Marks Growth of Biorational Product Segment in Agriculture March 13, 2012Valent BioSciences Signs Joint Testing Agreement with Pace International March 6, 2012Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Human and Animal Health January 18, 2012Osage, IA, and Valent BioSciences gear up for construction of landmark manufacturing facility April 25, 2011Valent BioSciences Corporation Announces Plan to Construct Fermentation Manufacturing Facility in Osage, Iowa July 20, 2010Valent BioSciences Corporation Achieves ISO 9001:2008 Registration for U.S. Operations August 20, 2009Valent BioSciences S-ABA Seed Treatment Receives Experimental Use Permit February 5, 2009Michael Donaldson named President and Chief Executive Officer
